Staurengo-Ferrari Larissa, Ruiz-Miyazawa Kenji W, Pinho-Ribeiro Felipe A, Fattori Victor, Zaninelli Tiago H, Badaro-Garcia Stephanie, Borghi Sergio M, Carvalho Thacyana T, Alves-Filho Jose C, Cunha Thiago M, Cunha Fernando Q, Casagrande Rubia, Verri Waldiceu A
Departamento de Ciências Patológicas, Universidade Estadual de Londrina, Londrina, Brazil.
Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Front Pharmacol. 2018 Oct 2;9:1123. doi: 10.3389/fphar.2018.01123. eCollection 2018.
Gouty arthritis is characterized by an intense inflammatory response to monosodium urate crystals (MSU), which induces severe pain and reduction in the life quality of patients. -Chalcone (1,3-diphenyl-2-propen-1-one) is a flavonoid precursor presenting biological activities such as anti-inflammatory and antioxidant proprieties. Thus, the aim of this work was to evaluate the protective effects of -Chalcone in experimental gout arthritis in mice. Mice were treated with -Chalcone (3, 10, or 30 mg/kg, per oral) or vehicle (Tween 80 20% plus saline) 30 min before intra-articular injection of MSU (100 μg/knee joint, intra-articular). We observed that -Chalcone inhibited MSU-induced mechanical hyperalgesia, edema, and leukocyte recruitment (total leukocytes, neutrophils, and mononuclear cells) in a dose-dependent manner. -Chalcone also decreased inflammatory cell recruitment as observed in Hematoxylin and Eosin (HE) staining and the intensity of fluorescence of LysM-eGFP+ cells in the confocal microscopy. -Chalcone reduced MSU-induced oxidative stress as observed by an increase in the antioxidant defense [Glutathione (GSH), Ferric Reducing (FRAP), and 2,2'-Azinobis-3-ethylbenzothiazoline 6-sulfonic acid (ABTS assays)] and reduction in reactive oxygen and nitrogen species production [superoxide anion (NBT assay) and nitrite (NO assay)]. Furthermore, it reduced MSU-induced interleukin-1β (IL-1β), Tumor necrosis factor-α (TNF-α), and IL-6 production, and increased Transforming growth factor-β (TGF-β) production. Importantly, -Chalcone reduced nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation and thereby the mRNA expression of the inflammasome components (cryopyrin), (apoptosis-associated speck-like protein containing a CARD), and . , -Chalcone reduced the MSU-induced release of IL-1β in lipopolysaccharide (LPS)-primed macrophages. Therefore, the pharmacological effects of -Chalcone indicate its therapeutic potential as an analgesic and anti-inflammatory flavonoid for the treatment of gout.
痛风性关节炎的特征是对尿酸单钠晶体(MSU)产生强烈的炎症反应,这会导致患者剧痛并降低生活质量。查尔酮(1,3 - 二苯基 - 2 - 丙烯 - 1 - 酮)是一种黄酮类前体,具有抗炎和抗氧化等生物活性。因此,本研究的目的是评估查尔酮对小鼠实验性痛风性关节炎的保护作用。在关节腔内注射MSU(100μg/膝关节,关节腔内注射)前30分钟,给小鼠口服查尔酮(3、10或30mg/kg)或赋形剂(20%吐温80加生理盐水)。我们观察到查尔酮以剂量依赖性方式抑制MSU诱导的机械性痛觉过敏、水肿和白细胞募集(总白细胞、中性粒细胞和单核细胞)。在苏木精和伊红(HE)染色中观察到查尔酮还减少了炎症细胞募集,并且在共聚焦显微镜下降低了溶菌酶M - eGFP +细胞的荧光强度。通过抗氧化防御增加[谷胱甘肽(GSH)、铁还原能力(FRAP)和2,2'-联氮 - 双 - 3 - 乙基苯并噻唑啉 - 6 - 磺酸(ABTS测定)]以及活性氧和氮物种产生减少[超氧阴离子(NBT测定)和亚硝酸盐(NO测定)],观察到查尔酮减轻了MSU诱导的氧化应激。此外,它降低了MSU诱导的白细胞介素 - 1β(IL - 1β)、肿瘤坏死因子 - α(TNF - α)和IL - 6的产生,并增加了转化生长因子 - β(TGF - β)的产生。重要的是,查尔酮降低了活化B细胞的核因子κB轻链增强子(NF - κB)的活化,从而降低了炎性小体成分(冷吡啉)、(含半胱天冬酶激活和招募结构域的凋亡相关斑点样蛋白)和的mRNA表达。此外,查尔酮减少了脂多糖(LPS)预处理的巨噬细胞中MSU诱导的IL - 1β释放。因此,查尔酮的药理作用表明其作为一种用于治疗痛风的镇痛和抗炎黄酮类药物具有治疗潜力。